Select a medication above to begin.
Rituxan Hycela
rituximab/ hyaluronidase
Black Box Warnings .
Severe Mucocutaneous Rxns
can occur, incl. fatal rxns
HBV Reactivation
can occur, incl. cases resulting in fulminant hepatitis, hepatic failure, and death; screen all pts for HBV infection before initial tx; monitor for s/sx HBV reactivation during tx and after D/C; D/C rituximab and concomitant drugs if HBV reactivation occurs
Progressive Multifocal Leukoencephalopathy
can occur, incl. fatal PML
Adult Dosing .
Dosage forms: INJ: 120 mg/2000 units per mL
Special Note
- [strength clarification]
- Info: doses expressed as rituximab amt; 1400 mg of combo contains 1400 mg rituximab + 23,400 units hyaluronidase; 1600 mg of combo contains 1600 mg rituximab + 26,800 units hyaluronidase
- [uses, dosing may vary]
- Info: refer to institution protocols and pkg insert prior to prescribing for uses, premeds, and dosing incl. toxicity-related dose adjustments
non-Hodgkin lymphoma, follicular
- [relapsed or refractory dz]
- Dose: 1400 mg SC qwk x3wk or x7wk, starting wk 2; Info: start after tolerating IV rituximab x1 at wk 1; give total 4 or 8wk of rituximab; may give additional 4wk tx (IV rituximab at wk 1, then SC rituximab qwk x3wk) in pts who progress after initial tx; give HBV prophylaxis before tx start, during tx, and for up to 12mo after D/C in anti-HBc positive pts
- [previously untreated dz]
- Dose: 1400 mg SC x1 on day 1 of 21-day cycle, starting cycle 2; Info: start after tolerating IV rituximab x1 on day 1 of cycle 1; give up to 8 cycles of rituximab as part of multi-drug chemo regimen; if complete or partial response, may give maint. monotherapy 1400 mg SC x1 on day 1 of 56-day cycle x12 cycles starting 56 days after combo chemo; give HBV prophylaxis before tx start, during tx, and for up to 12mo after D/C in anti-HBc positive pts
- [non-progressing dz]
- Dose: 1400 mg SC x1 on days 1, 8, 15, 22 of 6-mo cycle, starting cycle 2; Start: 1400 mg SC x1 on days 8, 15, 22 of cycle 1; Info: start after tolerating IV rituximab x1 on day 1 of cycle 1; give up to 16 doses (4 cycles) of rituximab; give HBV prophylaxis before tx start, during tx, and for up to 12mo after D/C in anti-HBc positive pts
non-Hodgkin lymphoma, diffuse large B-cell
- [1400 mg SC x1 on day 1 of each cycle, starting cycle 2]
- Info: for previously untreated dz; start after tolerating IV rituximab x1 on day 1 of cycle 1; give up to 8 cycles of rituximab; part of multi-drug chemo regimen; give HBV prophylaxis before tx start, during tx, and for up to 12mo after D/C in anti-HBc positive pts
CLL/SLL
- [1600 mg SC x1 on day 1 of 28-day cycle, starting cycle 2]
- Info: start after tolerating IV rituximab x1 on day 1 of cycle 1; give total 6 cycles of rituximab; part of multi-drug chemo regimen; give HSV and PCP prophylaxis during tx and up to 12mo after D/C; give HBV prophylaxis before tx start, during tx, and for up to 12mo after D/C in anti-HBc positive pts
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]
Peds Dosing .
Peds dosing is currently unavailable or not applicable for this drug.